Galapagos signs deal with Scipher for IBD drug development
admin 14th August 2020 Uncategorised 0Companies will jointly validate novel IBD targets More: Galapagos signs deal with Scipher for IBD drug development Source: News
read more
Companies will jointly validate novel IBD targets More: Galapagos signs deal with Scipher for IBD drug development Source: News
read moreClinical trial programme resumes after safety concerns More: Novo Nordisk resumes late-stage haemophilia trials Source: News
read moreCompany will manufacture over 25% more doses than previously planned More: AstraZeneca ships first doses of flu vaccine Source: News
read moreDeals agreed with Janssen and Novavax for another 90 million doses More: UK inks further coronavirus vaccine deals Source: News
read moreOn heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe esagonowsky Thu, 08/13/2020 – 13:33 More: On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe Source: fierce
read moreAstraZeneca, after prior issues with FluMist, ramps up production in response to pandemic esagonowsky Thu, 08/13/2020 – 09:42 More: AstraZeneca, after prior issues with FluMist, ramps up production in response to pandemic Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals